MarketPulse

major depressive disorder

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Brainsway Ltd.

BrainsWay Sets Q1 2026 Earnings Call for May 13 Amid Growing TMS Payer Support

BrainsWay will report Q1 2026 results May 13, highlighting expanding U.S. payer coverage for nurse practitioner-administered TMS therapy.
BWAYDeep TMSneurostimulation
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Xenon Pharma Raises $650M in Upsized Offering to Fund Pipeline Growth

Xenon Pharmaceuticals prices $650M upsized offering at $57/share with 10.5M shares. Proceeds fund pipeline acceleration; closes March 2026.
XENEpublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Brainsway Ltd.

BrainsWay Sets March 11 Date for 2025 Full-Year Results and Earnings Call

BrainsWay will release 2025 full-year financial results on March 11, 2026, followed by an 8:30 AM ET earnings call to discuss performance and operational updates.
BWAYfinancial resultsconference call